Locally Advanced Solid Tumors Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116
Recruiting
Phase 1
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.220 enrolled10 locationsNCT07050459